Booking Holdings (BKNG) stock today: Insider-sale notice surfaces as shares slip into weekend

Booking Holdings (BKNG) stock today: Insider-sale notice surfaces as shares slip into weekend

NEW YORK, January 3, 2026, 15:59 ET — Market closed

  • Booking Holdings shares fell 0.6% on Friday to close at $5,323.20, after trading between $5,293 and $5,351.
  • A Form 144 filing showed board chair Robert J. Mylod Jr. plans to sell 40 shares, worth about $214,271, through UBS Financial Services.
  • Online travel peers were mixed: Airbnb ended down 2.0% and Expedia slipped 0.1%.

Booking Holdings Inc’s common stock ended the week on the back foot after an SEC filing flagged a small planned insider sale late Friday.

The move comes as investors reset positioning at the start of a new year and test whether consumer demand for travel holds up against still-tight financial conditions.

Booking is closely watched because it sits at the intersection of discretionary spending, cross-border travel and currency moves, all of which can swing quickly when rate expectations shift.

A Form 144 filing showed Robert J. Mylod Jr., identified as chairman in the notice, intends to sell 40 Booking shares through UBS Financial Services. The filing also said the shares covered by the notice are being sold by Annox Capital LLC.

Form 144 is a required notice when an affiliate of a company plans to sell restricted or “control” shares under SEC Rule 144. It does not guarantee that a sale has taken place.

The notice also referenced a Rule 10b5-1 plan — a pre-arranged trading plan that can allow insiders to sell shares on a set schedule, helping separate trading from day-to-day news flow.

The filing stood out mostly for timing rather than size, with Booking trading at a high nominal share price that makes even small share counts look large in dollar terms.

The broader market tone was steadier on Friday, with U.S. stocks starting 2026 higher as investors looked ahead to next week’s labor-market data and what it may signal for Federal Reserve policy. “It’s very much ‘buy the dip, sell the rip’,” Joe Mazzola, head trading and derivatives strategist at Charles Schwab, told Reuters. Reuters

For Booking, investors typically focus on booking volumes, room nights and marketing efficiency, along with the company’s ability to protect margins when travel demand normalizes from peak periods.

Before trading resumes on Monday, the key question for the sector is whether the early-year bid in equities persists or gives way to fresh volatility around rates and the growth outlook.

Booking’s next major company-specific catalyst is quarterly results, with Zacks listing the next earnings report date as February 19, 2026. Investors will watch for updates on demand trends into early 2026 and any shifts in spending on performance marketing. Zacks

Technically, traders are likely to use Friday’s session range as a near-term roadmap, with the prior day’s low acting as initial support and the session high as a first resistance level.

Stock Market Today

  • Is Snap a Bargain After AR Push and Prolonged Slump?
    January 4, 2026, 8:47 PM EST. Snap trades near $8.13 and has climbed 3.4% this week, but remains down 32.1% year over year and well below its highs over multiple horizons. The company is pressing an augmented reality push and improving its advertising platform to bolster user engagement and monetization, even as competition from larger social platforms weighs on sentiment. A 4/6 valuation score flags multiple undervaluation checks, but deeper analysis matters. A DCF model puts intrinsic value at about $15.25 per share, implying roughly a 46.7% undervaluation vs. current price. The latest twelve-month free cash flow is about $390.4 million, with analysts modeling a rise toward $1.45 billion by 2030. For value work, price-to-sales can be a cleaner near-term yardstick for Snap.
McDonald’s stock starts 2026 lower: what MCD investors watch before Monday
Previous Story

McDonald’s stock starts 2026 lower: what MCD investors watch before Monday

Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom
Next Story

Pfizer stock today: PFE ends first 2026 session higher as pricing scrutiny returns and Feb. 3 results loom

Go toTop